111 related articles for article (PubMed ID: 9773756)
1. Course of distress experienced by persons at risk for an autosomal dominant inheritable disorder participating in a predictive testing program: an explorative study. Rotterdam/Leiden Genetics Workgroup.
Dudok deWit AC; Duivenvoorden HJ; Passchier J; Niermeijer MF; Tibben A
Psychosom Med; 1998; 60(5):543-9. PubMed ID: 9773756
[TBL] [Abstract][Full Text] [Related]
2. Psychological distress in applicants for predictive DNA testing for autosomal dominant, heritable, late onset disorders. The Rotterdam/Leiden Genetics Workgroup.
DudokdeWit AC; Tibben A; Duivenvoorden HJ; Frets PG; Zoeteweij MW; Losekoot M; van Haeringen A; Niermeijer MF; Passchier J
J Med Genet; 1997 May; 34(5):382-90. PubMed ID: 9152835
[TBL] [Abstract][Full Text] [Related]
3. Distress in individuals facing predictive DNA testing for autosomal dominant late-onset disorders: comparing questionnaire results with in-depth interviews. Rotterdam/Leiden Genetics Workgroup.
DudokdeWit AC; Tibben A; Duivenvoorden HJ; Niermeijer MF; Passchier J; Trijsburg RW
Am J Med Genet; 1998 Jan; 75(1):62-74. PubMed ID: 9450860
[TBL] [Abstract][Full Text] [Related]
4. Predicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress? Rotterdam Leiden Genetics Workgroup.
DudokdeWit AC; Tibben A; Duivenvoorden HJ; Niermeijer MF; Passchier J
J Med Genet; 1998 Sep; 35(9):745-54. PubMed ID: 9733033
[TBL] [Abstract][Full Text] [Related]
5. Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? Rotterdam/Leiden Genetics Working Group.
Lodder LN; Frets PG; Trijsburg RW; Meijers-Heijboer EJ; Klijn JG; Duivenvoorden HJ; Tibben A; Wagner A; van der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
J Med Genet; 1999 Dec; 36(12):906-13. PubMed ID: 10593998
[TBL] [Abstract][Full Text] [Related]
6. Predictive genetic testing for hereditary breast and ovarian cancer: psychological distress and illness representations 1 year following disclosure.
Claes E; Evers-Kiebooms G; Denayer L; Decruyenaere M; Boogaerts A; Philippe K; Legius E
J Genet Couns; 2005 Oct; 14(5):349-63. PubMed ID: 16195942
[TBL] [Abstract][Full Text] [Related]
7. Psychological effects of presymptomatic DNA testing for Huntington's disease in the Dutch program.
Tibben A; Duivenvoorden HJ; Niermeijer MF; Vegter-van der Vlis M; Roos RA; Verhage F
Psychosom Med; 1994; 56(6):526-32. PubMed ID: 7871108
[TBL] [Abstract][Full Text] [Related]
8. Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study.
Oberguggenberger A; Sztankay M; Morscher RJ; Sperner-Unterweger B; Weber I; Hubalek M; Kemmler G; Zschocke J; Martini C; Egle D; Dünser M; Gamper E; Meraner V
J Psychosom Res; 2016 Oct; 89():39-45. PubMed ID: 27663109
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
Lerman C; Narod S; Schulman K; Hughes C; Gomez-Caminero A; Bonney G; Gold K; Trock B; Main D; Lynch J; Fulmore C; Snyder C; Lemon SJ; Conway T; Tonin P; Lenoir G; Lynch H
JAMA; 1996 Jun; 275(24):1885-92. PubMed ID: 8648868
[TBL] [Abstract][Full Text] [Related]
10. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW
JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727
[TBL] [Abstract][Full Text] [Related]
11. Do Attachment Style and Emotion Regulation Strategies Indicate Distress in Predictive Testing?
van der Meer LB; van Duijn E; Giltay EJ; Tibben A
J Genet Couns; 2015 Oct; 24(5):862-71. PubMed ID: 25641254
[TBL] [Abstract][Full Text] [Related]
12. Risk reduction and health promotion behaviors following genetic testing for adult-onset disorders.
Beery TA; Williams JK
Genet Test; 2007; 11(2):111-23. PubMed ID: 17627380
[TBL] [Abstract][Full Text] [Related]
13. Attitudes toward direct predictive testing for the Huntington disease gene. Relevance for other adult-onset disorders. The Canadian Collaborative Group on Predictive Testing for Huntington Disease.
Babul R; Adam S; Kremer B; Dufrasne S; Wiggins S; Huggins M; Theilmann J; Bloch M; Hayden MR
JAMA; 1993 Nov; 270(19):2321-5. PubMed ID: 8230594
[TBL] [Abstract][Full Text] [Related]
14. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
[TBL] [Abstract][Full Text] [Related]
15. The psychological consequences of offering mutation searching in the family for those at risk of hereditary breast and ovarian cancer--a pilot study.
Broadstock M; Michie S; Gray J; Mackay J; Marteau TM
Psychooncology; 2000; 9(6):537-48. PubMed ID: 11180589
[TBL] [Abstract][Full Text] [Related]
16. Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutations.
Geirdal AØ; Reichelt JG; Dahl AA; Heimdal K; Maehle L; Stormorken A; Møller P
Fam Cancer; 2005; 4(2):121-6. PubMed ID: 15951962
[TBL] [Abstract][Full Text] [Related]
17. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.
Lodder L; Frets PG; Trijsburg RW; Tibben A; Meijers-Heijboer EJ; Duivenvoorden HJ; Wagner A; van Der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
Eur J Hum Genet; 2001 Jul; 9(7):492-500. PubMed ID: 11464240
[TBL] [Abstract][Full Text] [Related]
18. Cancer-related distress in unselected women with newly diagnosed breast or ovarian cancer undergoing BRCA1/2 testing without pretest genetic counseling.
Høberg-Vetti H; Eide GE; Siglen E; Listøl W; Haavind MT; Hoogerbrugge N; Bjorvatn C
Acta Oncol; 2019 Feb; 58(2):175-181. PubMed ID: 30334464
[TBL] [Abstract][Full Text] [Related]
19. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
20. Use of dietary supplements among women at high risk of hereditary breast and ovarian cancer (HBOC) tested for cancer susceptibility.
Alamian A; Rouleau I; Simard J; Dorval M
Nutr Cancer; 2006; 54(2):157-65. PubMed ID: 16898859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
